ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Down 10.7% in November

ICU Medical, Inc. (NASDAQ:ICUI) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 582,400 shares, a decrease of 10.7% from the October 31st total of 652,500 shares. Based on an average daily trading volume, of 257,300 shares, the short-interest ratio is presently 2.3 days. Currently, 2.6% of the company’s shares are short sold.

Analyst Ratings Changes

A number of research firms recently weighed in on ICUI. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Raymond James upped their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Finally, Jefferies Financial Group began coverage on ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

ICU Medical Stock Down 1.8 %

NASDAQ:ICUI traded down $3.00 during midday trading on Monday, reaching $160.96. 233,974 shares of the stock traded hands, compared to its average volume of 273,983. The business has a 50-day moving average of $174.60 and a two-hundred day moving average of $147.67. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 12-month low of $83.26 and a 12-month high of $196.26. The stock has a market capitalization of $3.94 billion, a PE ratio of -36.42 and a beta of 0.66.

Insider Activity at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total value of $2,141,520.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. This represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,364 shares of company stock worth $8,831,398. Company insiders own 6.70% of the company’s stock.

Institutional Investors Weigh In On ICU Medical

Several institutional investors have recently added to or reduced their stakes in ICUI. Innealta Capital LLC purchased a new stake in ICU Medical during the 2nd quarter worth approximately $32,000. Hexagon Capital Partners LLC lifted its stake in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 122 shares during the period. Allworth Financial LP grew its holdings in shares of ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of ICU Medical by 46.4% in the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 173 shares during the period. Finally, Venturi Wealth Management LLC raised its stake in ICU Medical by 1,510.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 302 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.